Jackson Creek Investment Advisors LLC Acadia Pharmaceuticals Inc Transaction History

Jackson Creek Investment Advisors LLC

  • $338 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
BUY
$20.78 - $31.77 $20 - $31
1 Added 0.0%
32,432 $1.02 Million
Q3 2023

Nov 03, 2023
SELL
$20.84 - $33.47 $311,849 - $500,845
-14,964 Reduced 31.57%
32,431 $676,000
Q2 2023

Aug 02, 2023
BUY
$17.8 - $25.65 $52,670 - $75,898
2,959 Added 6.66%
47,395 $1.14 Million
Q1 2023

May 02, 2023
BUY
$16.32 - $20.92 $725,195 - $929,601
44,436 New
44,436 $836,000

Others Institutions Holding ACAD

# of Institutions
279
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Jackson Creek Investment Advisors LLC Portfolio

Follow Jackson Creek Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email